Low Energy, High-Resolution Collimators Enhance Nuclear Medicine Imaging Capabilities

Two new collimators are attachment options for a gamma camera to help optimize imaging for their respective applications.

Dilon Technologies, Inc. (Newport News, VA, USA), a developer of molecular breast imaging, announced the release of two new collimators: the Slant15 collimator for breast imaging and the low energy, high-resolution (LEHR) collimator. Both collimators are attachment options for the Dilon 6800 gamma camera.


The Slant15 collimator is a 15o slant parallel-hole collimator that minimizes the dead space along the edge of the detector, allowing better visualization of the chest wall in breast imaging. Uses of this collimator include: breast imaging; sentinel node imaging; thyroid imaging; and parathyroid imaging.

The LEHR collimator is a high-resolution collimator for general nuclear medicine applications. The uses of this collimator include thyroid imaging, parathyroid imaging, sentinel node imaging, spot bone imaging, gall bladder ejection, and pediatric imaging studies.

"With the release of these new collimators, we are expanding breast imaging and general nuclear applications for the Dilon 6800 Gamma,” said Bob Moussa, president and CEO of Dilon Technologies. "This is another step in providing a broader service offering to clinicians.”

The Dilon 6800, is a high-resolution, small field-of-view gamma camera optimized to perform breast-specific gamma imaging (BSGI), a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake.

Related Links:
Dilon Technologies